Clinical Trial

An Exploratory Feasibility Study

Study acronym: Contextwell
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 19, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study explores the feasibility of ContextWell, a well-being education programme that combines an online webinar with an AI-powered behavioural nudging system. The programme aims to support university students, particularly those in healthcare disciplines, in enhancing well-being and adopting healthier lifestyle habits. The primary objective is to determine whether the programme can be feasibly delivered within university settings. A secondary objective is to assess its potential to improve student well-being and encourage behavioural changes aligned with lifestyle medicine principles. The intervention builds on the understanding that healthcare professionals' lifestyle habits and well-being have a direct impact on patient care. Focusing on healthcare students helps advance the integration of lifestyle medicine within health education and clinical practice. This single-group feasibility study delivers the full intervention to all participants. Students participate in an online well-being webinar and receive AI-generated behavioural prompts designed to promote self-awareness and healthier daily choices. Key evaluation measures will indicated the feasibility of the programme among young adults in academic environments. Participant feedback and initial outcomes will support future development and inform larger-scale research.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-03.
Trial Details
NCT Number NCT07009964
Lead Sponsor University College Dublin
Collaborators: UCD Clinical Research Centre, Ireland, University College Cork, Imperial College London
Conditions Well-Being, Lifestyle, Healthy, Young Adult, Behavior and Behavior Mechanisms
Enrollment 12 participants
Start Date 2025-11-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-19